Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ulipristal | The therapeutic efficacy of Promegestone can be decreased when used in combination with Ulipristal. |
| Lepirudin | Promegestone may decrease the anticoagulant activities of Lepirudin. |
| Bivalirudin | Promegestone may decrease the anticoagulant activities of Bivalirudin. |
| Alteplase | Promegestone may decrease the anticoagulant activities of Alteplase. |
| Urokinase | Promegestone may decrease the anticoagulant activities of Urokinase. |
| Reteplase | Promegestone may decrease the anticoagulant activities of Reteplase. |
| Anistreplase | Promegestone may decrease the anticoagulant activities of Anistreplase. |
| Tenecteplase | Promegestone may decrease the anticoagulant activities of Tenecteplase. |
| Abciximab | Promegestone may decrease the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Promegestone may decrease the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Promegestone may decrease the anticoagulant activities of Streptokinase. |
| Dicoumarol | Promegestone may decrease the anticoagulant activities of Dicoumarol. |
| Ardeparin | Promegestone may decrease the anticoagulant activities of Ardeparin. |
| Phenindione | Promegestone may decrease the anticoagulant activities of Phenindione. |
| Fondaparinux | Promegestone may decrease the anticoagulant activities of Fondaparinux. |
| Pentosan polysulfate | Promegestone may decrease the anticoagulant activities of Pentosan polysulfate. |
| Dipyridamole | Promegestone may decrease the anticoagulant activities of Dipyridamole. |
| Heparin | Promegestone may decrease the anticoagulant activities of Heparin. |
| Enoxaparin | Promegestone may decrease the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Promegestone may decrease the anticoagulant activities of Epoprostenol. |
| Coumarin | Promegestone may decrease the anticoagulant activities of Coumarin. |
| Ximelagatran | Promegestone may decrease the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Promegestone may decrease the anticoagulant activities of Desmoteplase. |
| Defibrotide | Promegestone may decrease the anticoagulant activities of Defibrotide. |
| Ancrod | Promegestone may decrease the anticoagulant activities of Ancrod. |
| Beraprost | Promegestone may decrease the anticoagulant activities of Beraprost. |
| Prasugrel | Promegestone may decrease the anticoagulant activities of Prasugrel. |
| Sulodexide | Promegestone may decrease the anticoagulant activities of Sulodexide. |
| Semuloparin | Promegestone may decrease the anticoagulant activities of Semuloparin. |
| Idraparinux | Promegestone may decrease the anticoagulant activities of Idraparinux. |
| Cangrelor | Promegestone may decrease the anticoagulant activities of Cangrelor. |
| Astaxanthin | Promegestone may decrease the anticoagulant activities of Astaxanthin. |
| Apixaban | Promegestone may decrease the anticoagulant activities of Apixaban. |
| Otamixaban | Promegestone may decrease the anticoagulant activities of Otamixaban. |
| Amediplase | Promegestone may decrease the anticoagulant activities of Amediplase. |
| Dabigatran etexilate | Promegestone may decrease the anticoagulant activities of Dabigatran etexilate. |
| Danaparoid | Promegestone may decrease the anticoagulant activities of Danaparoid. |
| Dalteparin | Promegestone may decrease the anticoagulant activities of Dalteparin. |
| Tinzaparin | Promegestone may decrease the anticoagulant activities of Tinzaparin. |
| (R)-warfarin | Promegestone may decrease the anticoagulant activities of (R)-warfarin. |
| Nadroparin | Promegestone may decrease the anticoagulant activities of Nadroparin. |
| Triflusal | Promegestone may decrease the anticoagulant activities of Triflusal. |
| Ditazole | Promegestone may decrease the anticoagulant activities of Ditazole. |
| Vorapaxar | Promegestone may decrease the anticoagulant activities of Vorapaxar. |
| Edoxaban | Promegestone may decrease the anticoagulant activities of Edoxaban. |
| Sodium citrate | Promegestone may decrease the anticoagulant activities of Sodium citrate. |
| Dextran | Promegestone may decrease the anticoagulant activities of Dextran. |
| Bemiparin | Promegestone may decrease the anticoagulant activities of Bemiparin. |
| Parnaparin | Promegestone may decrease the anticoagulant activities of Parnaparin. |
| Desirudin | Promegestone may decrease the anticoagulant activities of Desirudin. |
| Antithrombin Alfa | Promegestone may decrease the anticoagulant activities of Antithrombin Alfa. |
| Protein C | Promegestone may decrease the anticoagulant activities of Protein C. |
| Antithrombin III human | Promegestone may decrease the anticoagulant activities of Antithrombin III human. |
| Letaxaban | Promegestone may decrease the anticoagulant activities of Letaxaban. |
| Darexaban | Promegestone may decrease the anticoagulant activities of Darexaban. |
| Betrixaban | Promegestone may decrease the anticoagulant activities of Betrixaban. |
| Nafamostat | Promegestone may decrease the anticoagulant activities of Nafamostat. |
| Monteplase | Promegestone may decrease the anticoagulant activities of Monteplase. |
| Gabexate | Promegestone may decrease the anticoagulant activities of Gabexate. |
| Protein S human | Promegestone may decrease the anticoagulant activities of Protein S human. |
| Brinase | Promegestone may decrease the anticoagulant activities of Brinase. |
| Tioclomarol | Promegestone may decrease the anticoagulant activities of Tioclomarol. |
| Melagatran | Promegestone may decrease the anticoagulant activities of Melagatran. |
| Saruplase | Promegestone may decrease the anticoagulant activities of Saruplase. |
| (S)-Warfarin | Promegestone may decrease the anticoagulant activities of (S)-Warfarin. |
| Tocopherylquinone | Promegestone may decrease the anticoagulant activities of Tocopherylquinone. |
| Dabigatran | Promegestone may decrease the anticoagulant activities of Dabigatran. |
| Argatroban | Promegestone may decrease the anticoagulant activities of Argatroban. |
| Warfarin | Promegestone may decrease the anticoagulant activities of Warfarin. |
| Phenprocoumon | Promegestone may decrease the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Promegestone may decrease the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Promegestone may decrease the anticoagulant activities of 4-hydroxycoumarin. |
| Rivaroxaban | Promegestone may decrease the anticoagulant activities of Rivaroxaban. |
| Ethyl biscoumacetate | Promegestone may decrease the anticoagulant activities of Ethyl biscoumacetate. |
| Ticagrelor | Promegestone may decrease the anticoagulant activities of Ticagrelor. |
| Fluindione | Promegestone may decrease the anticoagulant activities of Fluindione. |
| Clorindione | Promegestone may decrease the anticoagulant activities of Clorindione. |
| Diphenadione | Promegestone may decrease the anticoagulant activities of Diphenadione. |
| Troxerutin | Promegestone may decrease the anticoagulant activities of Troxerutin. |
| Edetic acid | Promegestone may decrease the anticoagulant activities of Edetic acid. |
| Reviparin | Promegestone may decrease the anticoagulant activities of Reviparin. |
| Dermatan sulfate | Promegestone may decrease the anticoagulant activities of Dermatan sulfate. |
| SR-123781A | Promegestone may decrease the anticoagulant activities of SR-123781A. |
| Human C1-esterase inhibitor | The risk or severity of thromboembolism can be increased when Promegestone is combined with Human C1-esterase inhibitor. |
| Conestat alfa | The risk or severity of thromboembolism can be increased when Promegestone is combined with Conestat alfa. |
| Lymecycline | The serum concentration of Promegestone can be decreased when it is combined with Lymecycline. |
| Clomocycline | The serum concentration of Promegestone can be decreased when it is combined with Clomocycline. |
| Tigecycline | The serum concentration of Promegestone can be decreased when it is combined with Tigecycline. |
| Oxytetracycline | The serum concentration of Promegestone can be decreased when it is combined with Oxytetracycline. |
| Demeclocycline | The serum concentration of Promegestone can be decreased when it is combined with Demeclocycline. |
| Metacycline | The serum concentration of Promegestone can be decreased when it is combined with Metacycline. |
| Minocycline | The serum concentration of Promegestone can be decreased when it is combined with Minocycline. |
| Rolitetracycline | The serum concentration of Promegestone can be decreased when it is combined with Rolitetracycline. |
| Sarecycline | The serum concentration of Promegestone can be decreased when it is combined with Sarecycline. |
| Omadacycline | The serum concentration of Promegestone can be decreased when it is combined with Omadacycline. |
| Penimepicycline | The serum concentration of Promegestone can be decreased when it is combined with Penimepicycline. |
| Doxycycline | The serum concentration of Promegestone can be decreased when it is combined with Doxycycline. |
| Tetracycline | The serum concentration of Promegestone can be decreased when it is combined with Tetracycline. |
| Eravacycline | The serum concentration of Promegestone can be decreased when it is combined with Eravacycline. |
| Pitolisant | The serum concentration of Promegestone can be decreased when it is combined with Pitolisant. |